Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

April 21, 2017 - 12:01 p.m.
Gilead Announces Scientific Presentations Demonstrating Efficacy of Harvoni® (Ledipasvir/Sofosbuvir) in Special Patient Populations With HCV InfectionPrinter Friendly Version 
April 21, 2017 - 4:31 a.m.
Gilead Presents Proof-of-Concept Data for GS-0976 in Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017Printer Friendly Version 

Upcoming Events

Tuesday, May 2, 2017 4:30 p.m. ET
First Quarter 2017 Gilead Sciences Earnings Conference Call
Wednesday, May 10, 2017 10:00 a.m. PT
2017 Annual Meeting of Stockholders
LocationMillbrae, CA

Most Viewed Links

Updated 04/25/17
1.SEC Filings
2.Earnings
3.Annual Reports
4.Proxy Online
5.Stock Information
* Data collected 04/17/17 - 04/24/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.